chr5-174729165-T-G
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2
The NM_002449.5(MSX2):c.386T>G(p.Met129Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000558 in 1,613,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M129T) has been classified as Benign.
Frequency
Consequence
NM_002449.5 missense
Scores
Clinical Significance
Conservation
Publications
- craniosynostosis 2Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
- parietal foraminaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- parietal foramina with cleidocranial dysplasiaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- parietal foramina 1Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151942Hom.: 0 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251302 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461804Hom.: 0 Cov.: 51 AF XY: 0.00000825 AC XY: 6AN XY: 727208 show subpopulations
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151942Hom.: 0 Cov.: 30 AF XY: 0.0000135 AC XY: 1AN XY: 74184 show subpopulations
ClinVar
Submissions by phenotype
Cranium bifidum occultum Uncertain:1
This sequence change replaces methionine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 129 of the MSX2 protein (p.Met129Arg). This variant is present in population databases (rs4242182, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with MSX2-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MSX2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at